| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/06/2003 | CA2454183A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 02/06/2003 | CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | CA2453919A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452256A1 Methods of inducing differentiation of stem cells |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | CA2450073A1 Compositions and methods for modulating blood-brain barrier transport |
| 02/06/2003 | CA2448722A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 02/05/2003 | WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 02/05/2003 | EP1281763A2 Early growth response-1 (EGR-1) transcription factor |
| 02/05/2003 | EP1281756A1 Regulator of calcineurin |
| 02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1281404A2 Use of antibodies against the urokinase receptor |
| 02/05/2003 | EP1281399A2 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| 02/05/2003 | EP1281396A2 Skin vitalizing composition for external use anti-aging preparation |
| 02/05/2003 | EP1281392A1 Cosmetic or/and pharmaceutical compositions containing plant extracts |
| 02/05/2003 | EP1280932A1 Interfering with telomere maintenance in treatment of diseases |
| 02/05/2003 | EP1280921A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy |
| 02/05/2003 | EP1280918A2 Lipid metabolism enzymes |
| 02/05/2003 | EP1280909A2 Human lipocalin homologs and polynucleotides encoding the same |
| 02/05/2003 | EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 02/05/2003 | EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 02/05/2003 | EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 02/05/2003 | EP1280904A2 Pain signaling molecules |
| 02/05/2003 | EP1280903A2 Ph domain-interacting protein |
| 02/05/2003 | EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 02/05/2003 | EP1280898A1 Modified es cells and es cell-specific gene |
| 02/05/2003 | EP1280897A2 Regulation of nf-at interacting protein nip 45 variant |
| 02/05/2003 | EP1280896A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 02/05/2003 | EP1280827A1 Agonists/antagonists of the gpr56 receptor as appetite control agents |
| 02/05/2003 | EP1280823A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/05/2003 | EP1280820A2 Anti-inflammatory compounds and uses thereof |
| 02/05/2003 | EP1280812A1 Cyclipostins, a method for their production and the use of the same |
| 02/05/2003 | EP1280802A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 02/05/2003 | EP1280801A2 Hydantoin-containing glucokinase activators |
| 02/05/2003 | EP1280800A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280789A1 Cdk inhibitors having 3-hydroxychromen-4-one structure |
| 02/05/2003 | EP1280785A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands |
| 02/05/2003 | EP1280781A1 5-ht 7 receptor antagonists |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280774A1 Substituted indoles as parp inhibitors |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280759A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1280572A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280570A2 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280569A1 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280568A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280566A2 Growth factor modified protein matrices for tissue engineering |
| 02/05/2003 | EP1280554A2 A pharmaceutical composition and method of treatment of diseases of cognitive dysfuntion in a mammal |
| 02/05/2003 | EP1280547A2 Mast cell regulation |
| 02/05/2003 | EP1280544A1 Hyaluronidase activity and allergenic cell activity inhibitor |
| 02/05/2003 | EP1280536A2 Method for treating retinal degeneration with purinergic receptor agonists |
| 02/05/2003 | EP1280533A2 Aldosterone antagonist composition for release during aldosterone acrophase |
| 02/05/2003 | EP1280531A1 Local anesthetic methods and kits |
| 02/05/2003 | EP1280530A1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 02/05/2003 | EP1280529A2 Opioid antagonist containing composition for enhancing the potency or reducing adverse side effects of opioid agonists |
| 02/05/2003 | EP1280528A2 R-eliprodil for treating glaucoma |
| 02/05/2003 | EP1280525A2 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/05/2003 | EP1280524A2 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/05/2003 | EP1280522A2 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use |
| 02/05/2003 | EP1280519A1 Microprojectile delivery system and particulate product |
| 02/05/2003 | EP1280518A2 Liposome drug delivery |
| 02/05/2003 | EP1280512A2 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280500A2 Synergistic antiplaque/antigingivitis oral composition |
| 02/05/2003 | EP1280416A1 Pet food composition for reducing inflammatory response in cats |
| 02/05/2003 | EP1280409A1 A gene therapy system and method using alpha-msh and its derivatives |
| 02/05/2003 | EP1223918B1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 02/05/2003 | EP1196187A4 Keratinocyte growth factor-2 formulations |
| 02/05/2003 | EP1104294A4 Compositions and methods of treating abnormal cell proliferation |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP0993433B1 Method for producing calcium pyruvates |
| 02/05/2003 | EP0984960B1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists |
| 02/05/2003 | EP0909178B1 Interleukin-8 as an antiviral and antitumor agent |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors |
| 02/05/2003 | CN1395577A Ethanol solvate of (-)-cis-2-2(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-1methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395576A Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395565A Indole derivatives as MCP-1 receptor antagonists |
| 02/05/2003 | CN1395564A Indole derivatives as MCP-1 receptor antagonists |
| 02/05/2003 | CN1395560A Glyburide composition |
| 02/05/2003 | CN1395556A Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate |
| 02/05/2003 | CN1395490A Antigen-specific IgE antibody production inhibitors |
| 02/05/2003 | CN1395486A Drug combination for treatment of depression and related disorders comprising mirtazapine and gepirone |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394874A Human thio-oxidizing proteinoid gene and three-D space structure of its coded protein and physiologic function |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1394639A General anesthesia resuscitantanaleptic medicine |
| 02/05/2003 | CN1394631A Health-care food for resisting fatigue |
| 02/05/2003 | CN1394602A Benzoic acid substituted benzopyran fro curing atheroscleorsis |
| 02/05/2003 | CN1100785C 1,3,4,5-tetrahydrobenzo [c] azepin-3-one disulfide derivative and method |
| 02/05/2003 | CN1100779C 3-aryl substituted pyrazolo [4,3-d] pyriidine derivatives, corticotropin-releasing factor receptor (CRF1) specific ligands |